950210.KS
Price:
$6070
Market Cap:
$364.78B
Established in 2015 and based in Singapore, Prestige BioPharma Limited operates as a biopharmaceutical enterprise. The company's activities encompass the research, development, and commercialization of biosimilars and novel antibody therapeutics, primarily targeting the Asia Pacific market. A significant focus for Prestige BioPharma is the creation of antibody-based treatments for critical conditions such as solid tumors, pancreatic cancer, breast cancer, gastric cancer, and arthritis. Furthermore, the firm is also advancing the development of vaccines for the COVID-19 virus.
Industry
Biotechnology
IPO Date
2021-02-09
Stock Exchange
KSC
Ticker
950210.KS
According to Prestige BioPharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is 12.26. This represents a change of -232.69% compared to the average of -9.24 of the last 4 quarters.
The mean historical PE Ratio of Prestige BioPharma Limited over the last ten years is -2034.12. The current 12.26 PE Ratio has changed -160.27% with respect to the historical average. Over the past ten years (40 quarters), 950210.KS's PE Ratio was at its highest in in the December 2020 quarter at 5.21K. The PE Ratio was at its lowest in in the September 2020 quarter at -1302.08.
Average
-2034.12
Median
-16.12
Minimum
-10373.44
Maximum
39.66
Discovering the peaks and valleys of Prestige BioPharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 53.94%
Maximum Annual PE Ratio = 39.66
Minimum Annual Increase = -1093.31%
Minimum Annual PE Ratio = -10373.44
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | -3.30 | -108.32% |
| 2025 | 39.66 | -346.08% |
| 2024 | -16.12 | -149.87% |
| 2023 | 32.32 | -1093.31% |
| 2022 | -3.25 | -98.66% |
| 2021 | -242.65 | -75.78% |
| 2020 | -1001.80 | -90.34% |
| 2019 | -10373.44 | 53.94% |
The current PE Ratio of Prestige BioPharma Limited (950210.KS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.75
5-year avg
9.86
10-year avg
-2034.12
Prestige BioPharma Limited’s PE Ratio is less than Onconic Therapeutics (26.72), less than Medy-Tox Inc. (29.56), greater than GC Corp. (-27.91), less than Pharmicell Co., Ltd. (13.74), less than Orum Therapeutics, Inc. (27.44), greater than GC Corp. (-3.70), less than Chabiotech Co.,Ltd. (89.45), greater than Genomictree Inc. (-32.25), greater than BINEX Co., Ltd. (-7.26), less than Proteina Co., Ltd. (0),
| Company | PE Ratio | Market cap |
|---|---|---|
| 26.72 | $160.69B | |
| 29.56 | $439.28B | |
| -27.91 | $495.93B | |
| 13.74 | $639.64B | |
| 27.44 | $1.32T | |
| -3.70 | $447.94B | |
| 89.45 | $760.37B | |
| -32.25 | $296.28B | |
| -7.26 | $212.42B | |
| 0 | $401.48B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prestige BioPharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prestige BioPharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Prestige BioPharma Limited's PE Ratio?
How is the PE Ratio calculated for Prestige BioPharma Limited (950210.KS)?
What is the highest PE Ratio for Prestige BioPharma Limited (950210.KS)?
What is the 3-year average PE Ratio for Prestige BioPharma Limited (950210.KS)?
What is the 5-year average PE Ratio for Prestige BioPharma Limited (950210.KS)?
How does the current PE Ratio for Prestige BioPharma Limited (950210.KS) compare to its historical average?